Uhm, S.; Cho, Y.A.; Choe, J.-Y.; Park, J.W.; Kim, M.-J.; Han, W.-H.; Lee, J.; Lee, J.W.; Shin, D.W.; Soh, J.S.;
et al. Expression of Peptidyl Arginine Deiminase 2 Is Closely Associated with Recurrence in Patients with Hepatocellular Carcinoma. Diagnostics 2023, 13, 659.
https://doi.org/10.3390/diagnostics13040659
AMA Style
Uhm S, Cho YA, Choe J-Y, Park JW, Kim M-J, Han W-H, Lee J, Lee JW, Shin DW, Soh JS,
et al. Expression of Peptidyl Arginine Deiminase 2 Is Closely Associated with Recurrence in Patients with Hepatocellular Carcinoma. Diagnostics. 2023; 13(4):659.
https://doi.org/10.3390/diagnostics13040659
Chicago/Turabian Style
Uhm, Sunho, Yoon Ah Cho, Ji-Young Choe, Ji Won Park, Min-Jeong Kim, Won-Ho Han, Junyong Lee, Jung Woo Lee, Dong Woo Shin, Jae Seung Soh,
and et al. 2023. "Expression of Peptidyl Arginine Deiminase 2 Is Closely Associated with Recurrence in Patients with Hepatocellular Carcinoma" Diagnostics 13, no. 4: 659.
https://doi.org/10.3390/diagnostics13040659
APA Style
Uhm, S., Cho, Y. A., Choe, J.-Y., Park, J. W., Kim, M.-J., Han, W.-H., Lee, J., Lee, J. W., Shin, D. W., Soh, J. S., Lim, H., Kang, H. S., Moon, S.-H., & Kim, S.-E.
(2023). Expression of Peptidyl Arginine Deiminase 2 Is Closely Associated with Recurrence in Patients with Hepatocellular Carcinoma. Diagnostics, 13(4), 659.
https://doi.org/10.3390/diagnostics13040659
